ELIGIBLE MEDICARE PARTICIPANTS PAY ONLY $50/MONTH FOR WEGOVY®*
The Medicare GLP-1 Bridge is a program that gives eligible people with Medicare Part D access to obesity medications like Wegovy®. It is available from July 1, 2026 to December 31, 2027. Patients do not need to enroll in the program to participate.
Wegovy® is a prescription medicine for adults with obesity, or with overweight and at least one weight-related medical problem, along with a reduced-calorie diet and increased physical activity, to help you lose weight and keep it off.
*Eligibility criteria will be determined by Centers for Medicare & Medicaid Services (CMS). This information is not a guarantee of coverage. Month defined as 1 box of 4 pens of Wegovy® and 1 bottle of 30 tablets of Wegovy®.
3 THINGS TO KNOW WHEN GETTING WEGOVY® WITH MEDICARE:
1
TALK TO A DOCTOR
Once you and your doctor have decided that Wegovy® is right for you, your doctor will work with your pharmacist on the submission and approval process for the Medicare GLP-1 Bridge program to fill your prescription. You do not need to enroll in the Medicare GLP-1 Bridge program, but you must be on Medicare Part D to be eligible.
Call our NovoCare® Obesity & Bridge Support team at 888-809-3942 (Monday-Friday, 8:00 AM–8:00 PM ET).
2
TALK TO YOUR PHARMACIST
During the coverage approval process, there are several steps that will need to happen between the pharmacy and the Medicare GLP-1 Bridge program before your prior authorization is officially approved. It's a good idea to stay in contact with your pharmacist during that time. If you’re approved, you’ll pay your $50 copay,* receive your Wegovy® pen or pill prescription, and be on your way.
Call our NovoCare® Obesity & Bridge Support team at 888-809-3942 (Monday-Friday, 8:00 AM–8:00 PM ET).
3
WORK WITH YOUR CARE TEAM
You'll continue to work closely with your doctor, their staff, and your pharmacy to get your prescription each month.
Your doctor will help you with any medical needs and dosing changes, and your pharmacy will communicate with your doctor's office to fulfill your prescription. Your doctor and pharmacist are there to answer any questions you may have about your medicine.
Want ongoing support as you take Wegovy®? Check out WeGoTogether®.
Call our NovoCare® Obesity & Bridge Support team at 888-809-3942 (Monday-Friday, 8:00 AM–8:00 PM ET).
FAQs ABOUT THE MEDICARE GLP-1 BRIDGE PROGRAM
The Medicare GLP-1 Bridge is a temporary program starting July 1, 2026. It helps eligible Medicare Part D members access certain GLP-1 weight-loss medications, including Wegovy®. The program operates separately from regular Medicare Part D plans. Your doctor does not need to be enrolled in Medicare for you to be able to participate in this program.
To qualify for coverage of Wegovy® via the Medicare GLP-1 Bridge program, Medicare Part D beneficiaries must meet certain medical criteria and be enrolled in a standalone prescription drug plan (PDP) or Medicare Advantage (MA) coordinated care plan (eg, HMO, HMOPOS, and Local and Regional PPO plans) that offers prescription drug coverage (MA-PD plans).
The Medicare GLP-1 Bridge program currently covers all doses of Wegovy®—both pen and pill—for $50 per month,* as well as some forms and doses of other GLP-1 weight-loss medications.
*Eligibility criteria will be determined by Centers for Medicare & Medicaid Services (CMS). This information is not a guarantee of coverage. Month defined as 1 box of 4 pens of Wegovy® and 1 bottle of 30 tablets of Wegovy®.
Your healthcare professional will determine if you meet the medical criteria. You must be prescribed the medicine to reduce excess body weight and maintain weight reduction with ongoing lifestyle modification, such as a reduced-calorie diet and increased physical activity.
To medically qualify, you must be 18 or older and meet one of the following criteria:
Your body mass index (BMI) is 35 or higher
OR
Your BMI is 30 or higher and you have at least one of the following conditions:
- Heart failure (with preserved ejection fraction)
- Uncontrolled high blood pressure*
- Chronic kidney disease (stage 3a or above)
OR
Your BMI is 27 or higher and you have a history of:
- Pre-diabetes
- Heart attack
- Stroke
- Symptomatic peripheral artery disease
*Defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg, despite concurrent treatment with two blood pressure medicines.
You do not need to sign up for the Medicare GLP-1 Bridge program. The process begins by talking with a doctor. Once you and your doctor have decided that Wegovy® is right for you, your doctor will work with your pharmacist on the submission and approval process for the Medicare GLP-1 Bridge program to fill your prescription. You do not need to enroll in the Medicare GLP-1 Bridge program, but you must be on Medicare Part D to be eligible.
No. The Medicare GLP-1 Bridge program works outside of Medicare Part D. Your Medicare drug plan does not review, approve, or pay for prescriptions covered through this program. You do not need to sign up or enroll for the Medicare GLP-1 Bridge program.
If approved, you’ll pay $50 per month at your pharmacy when you fill your Wegovy® prescription.* The Medicare GLP-1 Bridge program covers the remaining cost of the medication.
The $50 per month copay will not count toward your Medicare Part D deductible or total out-of-pocket costs, since the Medicare GLP-1 Bridge is a separate program.
*Eligibility criteria will be determined by Centers for Medicare & Medicaid Services (CMS). This information is not a guarantee of coverage. Month defined as 1 box of 4 pens of Wegovy® and 1 bottle of 30 tablets of Wegovy®.
Pharmacists process prescriptions through a separate Medicare GLP-1 Bridge program system. You’ll pay the $50 monthly copay* at the pharmacy, and the pharmacy receives reimbursement directly from the program. Pharmacies do not need to opt-in to participate in the program.
*Eligibility criteria will be determined by Centers for Medicare & Medicaid Services (CMS). This information is not a guarantee of coverage. Month defined as 1 box of 4 pens of Wegovy® and 1 bottle of 30 tablets of Wegovy®.
The Medicare GLP-1 Bridge is a program that will exist from July 1, 2026 to December 31, 2027 to provide access to certain GLP-1 weight-loss medications, like Wegovy®, to eligible Medicare Part D beneficiaries. More information on continued coverage may become available at a later date. Sign up to be a WEGOVY® Insider to stay up-to-date on the latest Wegovy® news.
Become a WEGOVY® INSIDER
We'll keep you informed about any future Medicare GLP-1 Bridge program updates and Wegovy® news. Sign up for the latest sent right to your inbox.
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Wegovy® FlexTouch® pen: Do not share your Wegovy® FlexTouch® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy®?
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Important Safety Information
What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:
- Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
- Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Do not use Wegovy® if:
- you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets. See symptoms of serious allergic reaction in “What are the possible side effects of Wegovy®?”
Wegovy® FlexTouch® pen: Do not share your Wegovy® FlexTouch® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:
- have or have had problems with your pancreas or kidneys
- have type 2 diabetes and a history of diabetic retinopathy
- are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
- are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
- are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:
- inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back
- gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
- increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
- dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away
- severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
- serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
- change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
- increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
- food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
What is Wegovy®?
Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
- to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years
- to help children under 12 years of age lose weight and keep the weight off
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
FOLLOW US
Facebook
Instagram
TikTok